Peanut death inquest told of restaurant’s blank allergy forms
An inquest hears a restaurant linked to a peanut allergy death had incomplete documentation.
Similar Posts
Understanding Health Insurance: Choosing the Right Plan for Your Age and Lifestyle
Navigating the maze of health insurance options can be overwhelming, especially when trying to choose the best plan that suits your age, lifestyle, and health needs. Health insurance is crucial for managing medical costs and ensuring access to necessary healthcare services. Here’s a comprehensive guide to help you make an informed decision when selecting a…
New reason to skip alcohol, changing weight loss goals, and what smoking does to the brain
As weight-loss medications like Ozempic and Wegovy peak in popularity moving into the New Year, semaglutide experts believe these meds could make it more likely that people will stick with their resolutions. (SEBASTIEN BOZON/AFP via Getty Images) STICKING WITH IT – Ozempic and other weight-loss drugs may strengthen New Year’s resolutions, experts say. Continue reading……
Do You Have Peeing Issues? These Foods And Drinks May Be To Blame.
You’re likely familiar with foods that aren’t good for your heart. But when it comes to your bladder, it’s possible that you haven’t considered the correlation between diet and peeing. Unless you’ve had a urinary tract infection, suffered from a leaky bladder, or experienced the need to pee frequently, it may not have crossed your…
Should we be worried about Covid this winter?
Experts are not too concerned about a new variant of Covid but say monitoring should continue.
Most patients using weight-loss drugs like Wegovy stop within a year, data show | Reuters News Agency
Health 11 July 2023, 5:39 pm 1 minute Reuters exclusively reported that Only about one-third of patients prescribed a popular weight-loss drug like Novo Nordisk’s (NOVOb.CO) Wegovy were still taking it a year later, while total healthcare costs for the group rose sharply. Market Impact Shares of the Danish drugmaker fell 2.3% on Tuesday. Article…
